IMCLONE LOSES CANCER TREATMENT PATENT FIGHT

Shares of ImClone Systems Inc. fell over 6 percent on Tuesday after a court invalidated the biotechnology company's ownership of a key cancer drug patent. Trading volume for ImClone shares was heavy Tuesday, with more than 5 million shares changing hands in the first half hour of trading.

CNN Money (http://money.cnn.com/2006/09/19/news/companies/bc.health.imclone.reut/?postversion=2006091910)